Artelo Biosciences (ARTL) Stock Rockets 206% After Obesity Treatment Patent Filing

Artelo Biosciences (ARTL) stock skyrocketed 206% after filing a patent for obesity drug ART27.13, supported by promising weight-loss research data.

The post Artelo Biosciences (ARTL) Stock Rockets 206% After Obesity Treatment Patent Filing appeared first on Blockonomi.